A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a study to explore how well the combination of LY231514 and Gemcitabine work together
in patients with breast cancer that has spread beyond the location of the original tumor.
Patients must have previously received treatment with anthracycline and taxane chemotherapy
drugs.